Evidence map›Paper›PMID 34543094›Full record

ArticleAntimicrobial agents and chemotherapy2021

Intracellular Activity of Antibiotics against Coxiella burnetii in a Model of Activated Human THP-1 Cells.

Frédéric Peyrusson, Adam O Whelan, Margaret G Hartley, Isobel H Norville, Sarah V Harding, Françoise Van Bambeke

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Antibiotic persistence of intracellular Brucella abortus.PLoS neglected tropical diseases · 2022
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Frédéric PeyrussonPharmacologie cellulaire et moléculaire, Louvain Drug Research Institute, Université catholique de Louvaingrid.7942.8, Brussels, Belgium.
Adam O WhelanDefence Science and Technology Laboratorygrid.417845.b, Salisbury, United Kingdom.
Margaret G HartleyDefence Science and Technology Laboratorygrid.417845.b, Salisbury, United Kingdom.
Isobel H NorvilleDefence Science and Technology Laboratorygrid.417845.b, Salisbury, United Kingdom.
Sarah V HardingDefence Science and Technology Laboratorygrid.417845.b, Salisbury, United Kingdom.
Françoise Van BambekePharmacologie cellulaire et moléculaire, Louvain Drug Research Institute, Université catholique de Louvaingrid.7942.8, Brussels, Belgium.ORCID 0000-0002-0052-7991
Defence Science and Technology Laboratory · GBUCLouvain · BE

Funding

Belgian Fonds de la Recheche Scientifique T.0189.16Defense Science and Technology Laboratory DSTLX-1000145589
6 · The paper itself

Abstract

We evaluated antibiotic activity against the intracellular bacterium Coxiella burnetii using an activated THP-1 cell model of infection. At clinically relevant concentrations, the intracellular bacterial load was reduced 300-fold by levofloxacin and finafloxacin, 40-fold by doxycycline, and 4-fold by ciprofloxacin and was unaffected by azithromycin. Acidification of the culture medium reduced antibiotic activity, with the exceptions of doxycycline (no change) and finafloxacin (slight improvement). This model may be used to select antibiotics to be evaluated

Indexed as

Coxiella burnetiiQ FeverAnti-Bacterial AgentsCiprofloxacinDoxycyclineHumansTHP-1 CellsAnti-Bacterial AgentsCiprofloxacinDoxycyclineazithromycinciprofloxacinCoxielladoxycyclinefinafloxacinintracellular infectionlevofloxacin

Identifiers

PMID34543094
PMCPMC8597764
OpenAlexW3199284271

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.